BMR Medicine. Research Article

Similar documents
Journal of the American College of Cardiology Vol. 40, No. 10, by the American College of Cardiology Foundation ISSN /02/$22.

Ischemic heart disease is the leading cause of

Multiple Inflammatory Prognostic Factors in Acute Coronary Syndromes: A Prospective Inception Cohort Study

High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD)

The correlation of coronary artery involvement extent with white blood cell count in hospitalized patients

C-Reactive Protein and Angiographic Coronary Artery Disease: Independent and Additive Predictors of Risk in Subjects With Angina

A Comparative Evaluation of C-Reactive Protein as a Short-Term Prognostic Marker in Severe Unstable Angina A Preliminary Study

Evaluation of hs-crp levels in acute coronary syndromes

Prognostic Significance of High Sensitivity C-Reactive Protein before and after Percutaneous Coronary Intervention in Patients with Angina Pectoris

Statin pretreatment and presentation patterns in patients with acute coronary syndromes

Prognostic Value of C-Reactive Protein and Troponin T Level in Patients With Unstable Angina Pectoris C T KASANUKI, MD, FJCC

What do the guidelines say?

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Benefit of Performing PCI Based on FFR

Vascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians

Title for Paragraph Format Slide

Approach to Multi Vessel disease with STEMI

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Department of Rheumatology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, P.R. China 2

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

C- REACTIVE PROTEIN IN PATIENTS WITH NSTEMI ACUTE CORONARY SYNDROME

Acute Coronary Syndrome. Sonny Achtchi, DO

Methods and result: The Prospective observational study was carried out over the period of 2 yrs where

Nstemi But Stemi-De Winters Sign

Multiple lines of evidence indicate that inflammation

Pharmacologic Therapy of Coronary Disease

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction

The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

Journal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20.

JMSCR Vol 06 Issue 11 Page November 2018

New Insight about FFR and IVUS MLA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

Abstract Background: Methods: Results: Conclusions:

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center

Reeju Manandhar, Chaofeng Sun. Original article

10/17/16. Assessing cardiovascular risk through use of inflammation testing

Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting

Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-st elevation acute coronary syndromes?

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Comparison of Mean Platelet Volume in Acute Myocardial Infarction vs. Normal Coronary Angiography

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES

Belinda Green, Cardiologist, SDHB, 2016

Pathology of Coronary Artery Disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Best Lipid Treatments

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)

FFR Incorporating & Expanding it s use in Clinical Practice

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

CVD risk assessment using risk scores in primary and secondary prevention

Pathophysiology of Coronary Microvascular Dysfunction

Clinical Investigations

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

PCSK9 Inhibitors and Modulators

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Patient referral for elective coronary angiography: challenging the current strategy

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

The Role of Unknown Risk Factors in Myocardial Infarction

Current and Future Imaging Trends in Risk Stratification for CAD

Women and Coronary Artery Disease:

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

Between Coronary Angiography and Fractional Flow Reserve

12 Lead EKG Chapter 4 Worksheet

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

I t is becoming increasingly clear that inflammation plays a

Maria Angela S. Cruz-Anacleto, MD

FFR in Multivessel Disease

Of the 1.5 million heart attacks

Oral Disease as a Risk Factor for Acute Coronary Syndrome Single Center Experience

The Framingham Coronary Heart Disease Risk Score

CAD in Chronic Kidney Disease. Kuang-Te Wang

Diagnostic and Prognostic Value of Coronary Ca Score

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

QUT Digital Repository:

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Diabetes and Occult Coronary Artery Disease

Quinn Capers, IV, MD

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Kavitha Yaddanapudi Stony brook University New York

MULTIPLE COMPLEX CORONARY PLAQUES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Role of Inflammation Biomarkers and Coronary Artery Disease Analyzed According to Coronary Risk Factors

Data Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Moderate alcohol consumption is associated with decreased

Acute Coronary Syndromes

Transcription:

www.bmrjournals.com Open Access Scientific Publisher Research Article RELATIONSHIP BETWEEN WHITE BLOOD CELL (WBC) COUNT AND C-REACTIVE PROTEIN (CRP) WITH ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME Manish Ruhela 1,*, Anoop Jain, Neeraj Chaturvedi, Kushmendra Parashar, Om Prakash Khoja Department of Cardiology, Sawai Man Singh Medical College & Hospital, Jaipur, Rajasthan, India Correspondence should be addressed to Manish Ruhela Received 21 November 2014; Accepted 5 December 2014; Published 31 December 2014 Copyright: 2014 Manish Ruhela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACTS Background: Inflammation plays an important role in the initiation and progression of atherosclerosis and systemic blood markers of inflammation like white blood cell count and C-reactive protein have emerged as powerful predictor of coronary events. This study was carried out to evaluate the relationship between baseline white blood cell count and C-reactive protein with angiographic severity of coronary artery disease in patients with acute coronary syndrome and to identify those subsets of patients with acute coronary syndrome who may need to undergo invasive strategy. Method: A total of 100 patients with acute coronary syndrome including unstable angina, non-st elevation myocardial infarction and ST elevation myocardial infarction (not thrombolysed ) were evaluated in Department of Cardiology, Sawai Man Singh Medical College & Hospital, Jaipur, Rajasthan, India with a aim to correlate baseline white blood cell count and C-reactive protein with angiographic severity of coronary artery disease. Results: This study observed that raised white blood cell count and raised C-reactive protein independently and combination of both raised white blood cell count and CRP were significantly associated with angiographic more severe coronary artery disease in form of multi vessel disease,high stenosis score, more complex lesions and reduced TIMI flow grading. Conclusion: Raised white blood cell count and C- recactive protein in patient with acute coronary syndrome are associated with angiographic features of severe coronary artery disease. Both these markers can be used as a simpler tool for risk stratification patients with acute coronary syndrome. KEYWORDS: White Blood Cell Count, C -Reactive Protein, Angiographic Severity, Acute Coronary Syndrome INTRODUCTION Among the cardiovascular diseases acute coronary syndrome is the leading cause of death in developed country and second leading cause of death in developing country and by the year 2020, ischemic heart disease will hold first place in the World.[1] Major underlying mechanism of ischemic heart disease is atherosclerosis process in coronary arteries of heart. Atherosclerosis is a complex inflammatory fibro-proliferative response to retention of plasma derived atherogenic lipoproteins in the arterial intima.[2] Acute coronary syndrome has commonly been shown to occur as a result of the disruption of atherosclerotic plaque at a site of a high density of inflammatory cells.[3] Inflammation plays an important role in the initiation and progression of atherosclerosis and 1

2 systemic blood markers of inflammation including leukocyte count, C-reactive protein have emerged as powerful predictors of coronary events.[4] Freidman et al.[5] observed that an increased WBC count was associated with an increased risk of developing acute-mi and Schlant et al. observed that an elevated WBC count was predictor of post- MI mortality.[6] More recently Barron et al.[7]demonstrated that in setting of MI, an elevated WBC count was associated with reduced epicardial and myocardial perfusion and worse clinical outcomes. It is now appreciated that inflammation plays a central role in atherosclerosis and acute coronary syndrome.[8]this has led to renewed interest in the study of inflammatory markers, including C-reactive protein and more recently WBC count, in acute coronary syndrome. An inflammatory response is often found at the site of plaque rupture and even subtle elevations in CRP predict a higher rate of MI in otherwise healthy persons.[9] Ferreiros et al.[10] demonstrated that elevation of CRP indicates presence of evolving inflammation at the coronary plaque and in unstable angina, CRP is a strong independent marker of increased 90 days risk. In support of this relationship between inflammation and CAD, Sabatine et al.[11] observed that the extent of CAD found at angiography was related to the WBC count, even after adjusting for traditional risk factors. They also demonstrated that patient with a low CRP but an elevated WBC count remained at significantly higher risk of death at six months (p= 0.049) and patient with a high CRP were at even higher risk (p= 0.004). Current knowledge, however, suggests that the CRP concentration might reflect the vulnerability of the artheromatous lesion and likelihood of a plaque rupture.[8],[12],[13],[14]this acute phase reactant has been studied over the last several years in a wide variety of atherosclerotic disease. Its prognostic utility in acute coronary syndrome and ability to predict future coronary events in apparently healthy men and women[9],[15],[16] have been demonstrated. Zerbrack et al.[17] demonstrated such association between plasma hs-crp and the severity of coronary artery stenosis. C-reactive protein and CAD score independently and additively contributed to the risk prediction: low CRP and lowest CAD score was associated with lowest risk, and high CRP and highest CAD score was associated with the highest risk, with a 10-fold difference between extremes (2.5% vs. 24%). Thus WBC count and CRP may be both a marker of heightened inflammatory state and more extensive atherosclerosis disease burden and a direct contributor to coronary thrombosis and microvascular injury in the setting of plaque rupture. Baseline WBC count and CRP level are considered as significant predictors of CAD and risk of ACS. The aim of this study was establishing a potential relationship between levels of Total white blood cell count and CRP with the extent of angiographically documented coronary artery disease in Acute Coronary Syndrome patients. METHODS Study Method MD14 29 Volume1 Issue 1 2014 This was a prospective, observational study and conducted in SMS Medical College and Hospital, Jaipur, Rajasthan, India, in order to observe relationship between baseline WBC count and CRP level with angiographic findings in patients admitted with acute coronary syndrome. At first, total 130 patients diagnosed as a case of acute coronary syndrome including unstable angina, non- ST elevated myocardial infarction and ST elevated myocardial infarction who were not thrombolysed. Blood sample was drawn for WBC count and CRP level within 24 hours of symptoms which was considered as baseline sample. But angiogram was done only in 100 patients among them within 2 weeks of index event. So that finally a total of 100 patients fulfilled inclusion and exclusion criteria(patients was on statins for more than one month, Any systemic infection, Collagen vascular disease, Recent trauma,patients with documented extra-cardiac atherosclerosis, Prior PCI, Ac STEMI (Thrombolysed), Neoplastic disease, Pt who are taking anti-inflammatory drugs,immuno supressive drugs,anti neoplastic drugs, Women receiving HRT )and underwent coronary angiogram were selected for the study and classified into four groups Group I, Group II, Group III & Group IV according to the WBC count and CRP level. Group I included WBC countnormal (4000-11000/cmm) & CRP- normal < 2mg/ L, Group II included WBC count- raised (>11000/ cmm) & CRP- normal < 2mg/L, Group III included WBC countnormal (4000-11000/cmm) & CRP raised >2mg/L, Group IV included WBC countraised (>11000/cmm) & CRPraised > 2mg/L. Laboratory Method WBC count was done by manual method with use of Haemocytometer. CRP estimation was carried out by sensitive immunochemical quantitative method (Nephelometry system). Interpretation of coronary angiogram was done by one cardiologist to assess severity of coronary artery disease. In this study angiographic severity of coronary artery disease was assessed by vessel score, stenosis score, lesion morphology and TIMI flow grading. Vessel score:[18] Score ranged from 0 to 4, depending on the number vessels involved with a significant stenosis.(50% or greater luminal stenosis). Stenosis score:[18] The evaluation of degree of stenosis relates to the percentage reduction in the diameter of the vessel. By Gensini score, the lesions are roughly classified by visual estimation of reduction of luminal diameter. Lesion morphology:[19] Type A, Type B and Type C lesion established by a joint ACC/AHA task force. Culprit artery TIMI flow:[19] According to the TIMI grade flow in the culprit artery is defined by American College of Cardiology (TIMI Grade 0-3). Data Analysis Continuous variables were summarized as groups or as mean ± standard deviation (SD) and categorical data as frequencies and percentages. For continuous variables differences among groups were analyzed by Analysis of

Variance (Anova) test. The chi- square was applied to compare differences between discrete variables. For multiple comparisons a p value <0.05 was considered statistically significant. The whole analysis was done with the help of computer using SPSS (Statistical package for social science) program version 18. RESULTS Out of 100 patients 84 (84%) were male & 16 (16%) were female. The mean age of the study population was 52 ± 6.97 years ranging 38 to 72 years. Among the important risk factors of CAD, 55% patients were smoker, 28% patients were hypertensive, 24% patients were diabetic, 18% patients were dyslipidaemic and 7% having family history of. There distribution in the study groups was not statistically significant. (Table 1) Table 1: Baseline characteristics distribution among the study groups Characteristics Group I Group II Group III Group IV p value Age( years ) 52.21±5.09 53.30±4.88 52.75±7.02 52.47±6.97.93 Male 15 21 20 28.68 Female 4 5 4 3 Smoking 10 13 10 22.15 Hypertension 6 7 5 10.79 Diabetes 4 6 5 9.88 Dyslipidaemia 3 4 4 7.84 1 3 1 2.75 Table 2: Clinical pattern of presentation among study groups Clinical pattern Group I Group II Group III Group IV p value Unstable Angina 13 10 8 3.03 NSTEMI 2 9 7 7.29 STEMI 3 8 9 21.001 Among the distributions of clinical pattern of acute coronary syndrome, Unstable angina was significantly higher among the study I group (p < 0.05) and ST elevation MI was significantly higher among the study group IV (p<.05). (Table 2) Table 3: Distribution of Angiographic severity among study groups Character Group I Group II Group III Group IV p value Vessel Score 1.18±0.42 1.90±0.28 1.58±0.21 2.81±0.18 <0.05 Stenosis Score 18.76±3.19 28.80±9.3 24.3±8.98 40.2±18.4 < 0.05 Lesion morphology Simple 89% 82.2% 78.8% 64.12% 3

Lesion morphology Complex TIMI flow grading TIMI 0 2 11% 17.8% 21.2% 35.88% <0.05 13% 20.12% 24.18% 42.3% TIMI flow grading TIMI 3 87% 79.88% 75.82% 57.7% <0.05 Vessel score in Group I, Group II, Group III & Group IV were 1.18 ± 0.42, 1.70 ± 0.28, 1.98 ± 0.21, 2.81 ± 0.18 respectively which was statistically significant (p < 0.05). Stenosis score in group- I, group- II, group- III & group- IV were 18.76 ± 3.19, 21.8 ± 9.3, 28.30 ± 8.98 & 40.2 ± 18.4 respectively which was statistically significant (p < 0.05). Regarding morphology of the lesions, 89% were simple lesion and 11% were complex lesion in Group I, 82.2% were simple lesion and 17.8% were complex lesion in Group II, 78.8% were simple lesion and 21.2% were complex lesion in Group III, 64.12% were simple lesion and 35.88% were complex lesion in Group IV. The patients in Group IV had significantly higher number of complex lesions (35.88%) in comparison to patients in Group I (11%) and Group II and Group II & Group III had also higher than Group I which were statistically significant (p < 0.05). TIMI flow grading in culprit lesion,timi 0-2 in Group I,Group II, Group III and Group IV were 13%,20.12%,24.18%,42.3% respectively and TIMI 3 in Group I,Group II, Group III and Group IV were 87%,79.88%,75.82%,57.7% respectively which was statistically significant ( p<.05 ). (Table 3) Multivariate analysis (Table 4, Table 5) for predicting angiographic severity of coronary artery disease in form of vessel score and stenosis score showed that raised total WBC count and CRP level were the independent predictors of severe coronary artery disease. Other risk factors like smoking, hypertension, diabetes, dyslipidaemia, and family history of were not found independent predictors of severe coronary artery disease. Table 4a : Prediction of stenosis score in relation to white blood cell count (WBC count) and other risk factors multivariate analysis Fixed Variable 0.999.001 WBC Count Co- Variables Smoking.38.16 Hypertension.54.40 Diabetes.26.34 Dyslipidaemia.17.26.05.72 Table-4b: Prediction of stenosis score in relation to white blood cell count (WBC count ) and other risk factors multivariate analysis 4 Fixed Variable 0.999.001 MD14 29 Volume1 Issue 1 2014

WBC Count Co- Variables Smoking.57.078 Hypertension.42.070 Diabetes.38.097 Dyslipidaemia.24.21.03.92 Table 5a: Prediction of stenosis score in relation to CRP and other risk factors multivariate analysis Fixed Variable 0.997.001 CRP level Co-variables Smoking.22.10 Hypertension.14.38 Diabetes.35.28 Dyslipidaemia.21.19.06.88 Table 5b: Prediction of stenosis score in relation to CRP and other risk factors multivariate analysis Fixed Variable 0.999.001 CRP level Co-variables Smoking.12.56 Hypertension.36.11 Diabetes.34.19 Dyslipidaemia.27.24.07.98 DISCUSSION This was a prospective, observational study and conducted in Department of Cardiology, SMS Medical College and Hospital, jaipur, Rajasthan, India in order to observe relationship between baseline WBC count and CRP level with angiographic findings in patients admitted with acute coronary syndrome. This study observed that either raised WBC count or CRP level or combination of raised WBC count & CRP level were significant predictor of multivessel disease and high stenosis score. In our study, we observed angiographic severity in relation to WBC count and found that raised WBC count group was associated with high stenosis score, (28.8 ±9.3 vs 18.76 ±3.19, p value < 0.05) and high vessel score (1.90 ± 0.28 vs 1.18 ± 0.42, p value < 0.05) were also statistically 5

6 significant. This was consistent with findings of Sabatine et al,[11] in that study they observed high WBC count was a significant predictor of multivessel disease (p =0.018) and a statistically significant correlation between baseline WBC count and the overall extent of a patient s CAD (Stenosis > 50%) (p< 0.001). Angiographic severity in relation to isolated to CRP was also observed in our study. Raised CRP group was associated with high stenosis score (24.3 ±8.98 vs 18.76 ±3.19, p value < 0.05) and high vessel score (1.58 ±0.21 vs 1.18 ± 0.42, p value < 0.05) which were statistically significant. This was consistent with findings of Nyandak et al.[20] in that study they observed that higher hs- CRP levels were associated with higher stenosis in CAD patients. In our study, regarding morphology of the lesion we also observed higher WBC count and CRP level were associated with more complex lesion (Type B & Type C lesion). We found 35.88% complex lesion in Group IV and 11 % complex lesion in Group I, which was statistically significant (p< 0.05). Avanzas et al.[21] correlated CRP level with the number of complex stenosis. Zairis et al.[22]demonstrated that with increasing of CRP tertile a significant increase in either the number of multiple complex lesions or presence of apparently thrombus containing lesions. We have demonstrated that elevated WBC count and CRP level were associated with reduced TIMI flow of culprit vessel in the setting of acute coronary syndrome. In our study we observed that in patients having normal WBC count and normal CRP level 87% of patients were having TIMI-3 flow grading and those having raised WBC count and CRP level, 57.7% of patients were having TIMI -3 flow grading which was statistically significant (p<.05). This is consistent with the findings of Sabatine et al[11] and Baron et al.[7]. They observed elevations in baseline WBC count are associated with reduced epicardial and myocardial blood flow. Barron et al. observed that patients with a closed infarct related artery at 90 mins (TIMI grade 0 or I flow) had a higher WBC count than did patients with an open artery ( p = 0.01).Sabatine et al.[11] observed that the baseline WBC count was higher in patients with worse culprit artery TIMI flow grading ( P = 0.007). Moukarbel GV et al.[23] also found that elevated CRP level on admission was a marker for anatomic complexity of culprit lesion and worse perfusion grading in patients with elevated CRP (p = 0.007) and ctnt levels (p = 0.027). Limitations a. Number of study population was limited. b. Angiography was evaluated by visual estimation so there was chance of inter observer and intra observer variation of interpretation of the severity of stenosis. CONCLUSION We can conclude from this study that either raised WBC count or raised CRP level independently and combination of both were significantly associated with angiographic feature of more severe coronary artery disease in form of multi vessel disease, high stenosis score, complex lesions and worse TIMI flow gradings. Thus WBC count and CRP can be used as a simpler tool for risk stratification in patients with acute coronary syndrome. REFERENCES [1] Murray CJ, Lopez AD. Mortality by cause for eight region of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276. [2] Williams KJ, Tabes L. The response to retention hypothesis of atherosclerosis reinforced. Circulation 1998; 91: 111-120. [3] Vander Wal AC, Becker AE, Vander loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerosis plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44. [4] Danes J, Collins S, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin and leukocyte count with coronary heart disease; Meta-analysis of prospective studies. JAMA 1998; 279:477-1482. [5] Fridman GD, Klatsky AI, Siegelaub AB. Leukocyte count and myocardial infarction. N Engl J Med 1974; 291: 1360-1361. [6] Schlant RC, Forman S, Stamler J, Canner PL. The natural history of coronary heart disease; prognostic factors after recovery from myocardial infarction. Circulation 1982; 66: 401-414 [7] Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between WBC count, epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute myocardial infarction. Am J Cardiol 2003; 38: 426-429. [8] Libby P, Ridker PM. Novel inflammatory markers of coronary risk. Circulation 1999; 100:1148-1150. [9] Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin and the risk of cardiovascular disease in apperantly healthy man. N Engl J Med 1997; 336: 973-979. [10] Ferreiros ER, Boissonnet CP, Pizarro R. Independent prognostic value of elevated C- reactive protein in unstable angina. Circulation 1999;100:1958-1963. [11] Sabatine MS, Marrow DA, Cannon CID, et al. Relationship between white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndrome. J Am Col Cardiol 2002; 40: 1761-1768. [12] Ross R. Atherosclerosis- an inflammatory disease. N Eng J Med 1999; 340: 115-126. [13] Miseri A. Inflammation, atherosclerosis and ischemic events- exploring the hidden side of the moon. N Eng J Med 19997; 336: 1014-1016. [14] Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Miseri A. The prognostic value of Creactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424 [15] Ridker PM, Buring JE,Shih J, Matias M, Hannekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events MD14 29 Volume1 Issue 1 2014

among apparently healthy women. Circulation 1998; 98: 731-733. [16] Ridker PM, Hennekens CH, Buring JE, Rifai N. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEng J Med 2000; 42: 836-834. [17] Zabrak JS, Muhlestein JB, Home BD, Anderson JL. Intermountain Heart Collaboration Study Group, Creactive protien and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cordiol 2002; 39: 632-637. [18] 18. Sullivan DR, Marwick TR, Freedman SB. A new method of scoring coronary angiogram to reflect extent of coronary atherosclesros and improve correlation with major risk factors. Am Heart J 1990; 119: 1262. [19] Cannon CP, Battler A, Brindis RG. ACC Clinical Data Standards, American College of Cardiology key data elements and definitions for clinical management and outcomes of patients with acute coronary syndrome: A report of the American College of Cardiology Task Force of clinical data standards (Acute coronary syndrome writing committee. J Am Coll Cardiol 2001; 38:2114-2130. [20] Nyandak T, Gogna A, Bansal S, Deb M. High sensitivity C-reactive protein (hs-crp) and its correlation with angiographic severity of coronary artery disease. JIACM 2007; 8: 217-221. [21] Avanzas P, Arroyo E, Spliguero R et al. Markers of inflammation and multiple complex stenosis (pancoronary plaque vulnerability) in patients with non ST segment elevation acute coronary syndrome). Heart 2004;90: 847-852. [22] Zaires MN, Papadaki OA, Maousakis SJ et al. C- reactive protein and coplex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002;164 (2): 355-359. [23] Moukarbel GV, Arnsout MS, Alam SE. C- reactive protein is a marker for a complex culprit anatomy in unstable angina. Clin Cardiol 2001; 24(7): 506-510. 7